Ardiyon Bio
PrivateLast Round
Accelerator
Jan 1, 2025
Total Funding Raised
$40,000
Company Overview
Ardiyon Bio is a biotechnology company developing a targeted enzyme replacement therapy for systemic lupus erythematosus and related autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ardiyon Bio Comparables
Compare Ardiyon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neutrolis Inc | 86% | |
| Resolve Therapeutics | 76% | |
| AstraZeneca | 66% |
Ardiyon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2025 |
Ardiyon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Texas Tech Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
$40K round from Texas Tech Accelerator
Ardiyon Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ardiyon Bio's valuation, stock price, and market status.
Is Ardiyon Bio a public or private company?
Ardiyon Bio is a private company.
What is the current stock price of Ardiyon Bio?
Ardiyon Bio is a private company, so its shares have no public market price. Caplight tracks Ardiyon Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ardiyon Bio worth (valuation)?
Valuation information for Ardiyon Bio is not publicly available.
Can I buy Ardiyon Bio stock?
Ardiyon Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ardiyon Bio's last funding round?
Ardiyon Bio's most recent funding round was Accelerator on January 1, 2025.
Who are the main investors in Ardiyon Bio?
Key investors in Ardiyon Bio include Texas Tech Accelerator.
Will Ardiyon Bio IPO soon?
No public IPO plans have been announced for Ardiyon Bio.
How can I track Ardiyon Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ardiyon Bio's shares on secondary markets.